...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >A COMPARATIVE EVALUATION OF THERAPEUTIC EFFICACY AND SAFETY OF THE CRYOTHERAPY (LIQUID NITROGEN) WITH TOPICAL 20percent PODOPHYLLIN V/S INTRALESIONAL BLEOMYCIN WITH TOPICAL 5percent PLACENTREX GEL IN THE TREATMENT OF CONDYLOMA ACUMINATA
【24h】

A COMPARATIVE EVALUATION OF THERAPEUTIC EFFICACY AND SAFETY OF THE CRYOTHERAPY (LIQUID NITROGEN) WITH TOPICAL 20percent PODOPHYLLIN V/S INTRALESIONAL BLEOMYCIN WITH TOPICAL 5percent PLACENTREX GEL IN THE TREATMENT OF CONDYLOMA ACUMINATA

机译:含20%PODOPHYLIN V / S内溶血球菌素与5%CENTREREXEL凝胶治疗尖锐湿疣的冷冻疗法(液氮)的疗效和安全性的对比评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background : Condyloma acuminata is a common sexually transmitted disease of sexually active adults caused by HPV having variable response to the different available therapies and none of them have proved to be uniformly effective as recurrences are common. Objective : A randomized, single blinded, paralleled group, intention to treat prospective study was conducted not only to compare the two treatment modalities but also to determine the efficacy and safety of drugs under study. Materials and Methods : 60 cases of clinically diagnosed condyloma acuminata were randomly divided into two equally matched groups (n=30). Group-I, patients were treated with a combination of cryotherapy (liquid nitrogen) with topical 20percent podophyllin and Group-II, patients were treated with a combination of intralesional bleomycin with topical 5percent placentrex gel. Evaluation criteria included assessment of lesion response, patient’s response, duration of response, recurrence rate and safety. Photographic assessment at baseline, 2, 4, 8, 12 and 24 weeks was done. Results : 289 condylomas were treated in total (n=60), 175 (60.55percent) Group-I and 114(39.4percent) in Group-II . 49 patients completed the study, 24 treated in Group-I and 25 in Group-II. By intention to treat, lesional clearance rate at 24 weeks in Group-I was 80percent as compared to 83.33percent in Group-II. The clinical efficacy of combination therapy in Group-II was higher as compared to Group-I but there was no statistically significant difference between both the groups (p greater than0.05). The side effects evaluated in this study were mild and transient and they were assessed using a 4 point clinical score (0=absent, 1=mild, 2=moderate, and 3=severe). Conclusion : In this comparative study Intralesional bleomycin with 5percent placentrex gel was found to be more effective although both treatment modalities have good potential for treatment of condyloma.
机译:背景:尖锐湿疣是由HPV引起的对有性活动的成年人进行性传播的常见疾病,对不同的可用疗法有不同的反应,但由于复发很普遍,没有一种被证明具有统一的疗效。目的:进行了随机,单盲,平行分组的治疗前瞻性研究的意向,不仅比较了两种治疗方式,还确定了所研究药物的疗效和安全性。材料与方法:将60例临床诊断为尖锐湿疣的患者随机分为两组,每组30例。第一组患者接受冷冻治疗(液氮)与局部用20%鬼臼毒素的组合治疗,第二组患者接受病灶内博莱霉素与局部用5%胎盘胶结合的治疗。评估标准包括对病变反应,患者反应,反应持续时间,复发率和安全性的评估。在基线第2、4、8、12和24周进行了摄影评估。结果:共治疗con突病289例(n = 60),Ⅰ组175例(60.55%),Ⅱ组114例(39.4%)。 49名患者完成了研究,其中I组治疗24例,II组治疗25例。通过治疗,第一组24周的病变清除率为80%,而第二组为83.33%。组II中联合治疗的临床疗效高于组I,但两组之间无统计学差异(p大于0.05)。在这项研究中评估的副作用是轻度和短暂的,并使用4分临床评分(0 =不存在,1 =轻度,2 =中度和3 =严重)对其进行评估。结论:在本对比研究中,发现Intraesional博来霉素与5%的胎盘凝胶比较有效,尽管两种治疗方式均具有治疗尖锐湿疣的良好潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号